Bayer AG (BUE:BAYN) Other Stockholders Equity : ARS13,579,818 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Bayer AG Other Stockholders Equity?

Bayer AG's Other Stockholders Equity for the quarter that ended in Mar. 2024 was ARS13,579,818 Mil.

Bayer AG's quarterly Other Stockholders Equity increased from Sep. 2023 (ARS4,707,332 Mil) to Dec. 2023 (ARS4,783,545 Mil) and increased from Dec. 2023 (ARS4,783,545 Mil) to Mar. 2024 (ARS13,579,818 Mil).

Bayer AG's annual Other Stockholders Equity increased from Dec. 2021 (ARS1,397,199 Mil) to Dec. 2022 (ARS3,196,183 Mil) and increased from Dec. 2022 (ARS3,196,183 Mil) to Dec. 2023 (ARS4,783,545 Mil).

Bayer AG Other Stockholders Equity Historical Data

The historical data trend for Bayer AG's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Other Stockholders Equity Chart

Bayer AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

1,758,472.90

964,976.68

1,397,199.48

3,196,183.20

4,783,545.26

Bayer AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Stockholders Equity	Get a 7-Day Free Trial															4,248,805.63	4,205,070.42	4,707,331.86	4,783,545.26	13,579,817.94

Bayer AG Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Bayer AG Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Bayer AG's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Bayer AG (BUE:BAYN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (BUE:BAYN) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

BAYZF:USA BAYRY:USA BAYN:Romania BAY:Poland BAYN:Mexico BAY:Italy BAYER:Hungary 0P6S:UK BAYNd:UK BAYN:Germany BAYN:Austria

Address

Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368

Website

https://www.bayer.com

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Bayer AG (BUE:BAYN) Headlines

From GuruFocus

Oakmark International Fund Buys Fresenius Medical Care AG. KGaA, Anheuser-Busch InBev SA/NV, Bayer AG, Sells NAVER Corp, Daimler AG, Valeo SA

By GuruFocus Research GuruFocus Editor • 11-30-2020

Oakmark International Fund Buys Bayer AG, Roche Holding AG, Fresenius Medical Care AG. KGaA, Sells BNP Paribas, Baidu Inc, CNH Industrial NV

By GuruFocus Research GuruFocus Editor • 03-01-2021

Market Indexes Lower as Market Considers Outlook

By Julie Young Julie Young • 05-23-2016

Analysts Think Bayer Shares Have Huge Upside

By Barry Cohen Barry Cohen • 03-04-2019

David Herro Comments on Bayer

By Holly LaFon Holly LaFon • 04-06-2018

Bayer AG Expects Currency to Ding Earnings by $191.5 Million

By Jacob Maslow Jacob Maslow • 05-21-2018